hair loss. Nonscarring hair loss, unspecified
Conditions
Interventions
Intervention group: Topical use of Caffeine Plus Irox anti-hair loss serum produced by Iran Avandfar company(Contains Canadian willow extract, Glycolic extract of green tea, Caffeine , etc..)20 drops
Sponsors
Iran Avandfar Company
Eligibility
Sex/Gender
Male
Age
18 Years to 50 Years
Inclusion criteria
Inclusion criteria: Male aged 18-55 years Good general health Voluntary participation and sign the written informed consent Hair Loss Status II, III, IV based on Norwood Scale
Exclusion criteria
Exclusion criteria: Chronic active scalp disease other than hair loss Using any prescribed drug or OTC for hair loss within the past 3 months People with allergies to serum and shampoo ingredients Any severe weight loss or strict diet therapy during the study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Hair lost Changes, based on Global photographic review. Timepoint: Before intervention, 6 and 12 weeks after the start of use. Method of measurement: One independent dermatologist will perform clinical assessments in a blinded fashion by scoring every photograph according to the Global photographic review scale . | — |
Secondary
| Measure | Time frame |
|---|---|
| Hair count changes. Timepoint: Before intervention, 6 and 12 weeks after the start of use. Method of measurement: Trichoscopy By Fotofinder.;Changes in percentage of anagen to telogen. Timepoint: Before intervention, 6 and 12 weeks the start of use. Method of measurement: Trichoscopy By Fotofinder. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactAniseh Samadi
Tehran University of Medical Sciences
Outcome results
None listed